Clinical trial
A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth…
NCT00455728 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00455728 |
|---|---|
| Title | A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders |
| Official title | International Cooperative Growth Study (iNCGS) Post Marketing Surveillance Program for NutropinAq® [Somatropin (rDNA Origin) Injection] |
| Acronym | iNCGS |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Growth Hormone Disorders |
| Enrollment | 3,690 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2016 |
| Completion | Dec 1, 2016 |
| First posted | Apr 4, 2007 |
| Last update posted | Jan 7, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: